BIOVIA, a part of Dassault Systèmes, provides a scientific collaborative environment for advanced biological, chemical and materials experiences that help science - and process - driven companies develop better products faster and more cost effectively in regulated and non-regulated environments. BIOVIA’s sophisticated enterprise solutions of collaborative science, unified lab management, process production operations and quality/regulatory management allow customers to discover, design, deploy and deliver innovative sustainable and competitive products of higher quality to consumers globally. Using BIOVIA technology organizations can access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and accelerating product development throughout the product lifecycle from early product ideation through R&D to QA/QC and manufacturing. BIOVIA solutions are used by more than 2,000 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries.
Many organizations in the pharmaceutical and biopharmaceutical industries have increased their efforts in biotherapeutic drug development to be successful and remain competitive by shifting the activities away from small molecule toward biologics drug development.
In today’s pharmaceutical manufacturing industry, there are major challenges with getting the data you need from all the disparate sources and paper records across the organization in order to make business decisions.
Typical paper-based Quality Testing systems are not only inefficient and extend process times; they are also the one overarching cause of high compliance risk.
In today’s pharmaceutical manufacturing industry, there are major challenges with getting the data you need from all the disparate sources and paper records across the organization in order to make business decisions.
